| - | uL/min/10^6 cells | Clint | - | Human | NTP_ICE_adme_parameters |
| 2.375 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 4 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 11 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 31.25 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.5 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 3.333 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 10 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 25 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| IWW5FV6NK2 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| IWW5FV6NK2 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| IWW5FV6NK2 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| IWW5FV6NK2 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 8.62e-9 | fraction | Fu | - | Human | NTP_ICE_adme_parameters |
| 3 | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 3 | unitless | IARC group | - | - | NTP_ICE_cancer |
| - | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 1.053 | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 4.545 | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 12.5 | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 348.8 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 3488 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 6207 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 13950 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 15520 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 1657 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 2483 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 6828 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 19400 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 2069 | ug/cm2 | Induction dose per skin area, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 0.34 | mg/L | LC50 | Inhalation | - | NTP_ICE_acute_inhalation |
| =6 | mg/kg bw | LD50 | oral | Rat (Male) | NTP_ICE_acute_oral |
| =9 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =25 | mg/kg bw | LD50 | oral | Rat (Male) | NTP_ICE_acute_oral |
| =56 | mg/kg bw | LD50 | oral | Rat (Female) | NTP_ICE_acute_oral |
| =60 | mg/kg bw | LD50 | oral | Rat (Male/Female) | NTP_ICE_acute_oral |
| =63 | mg/kg bw | LD50 | oral | Rat (Female) | NTP_ICE_acute_oral |
| =66 | mg/kg bw | LD50 | oral | Rat (Male) | NTP_ICE_acute_oral |
| =104 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =120 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =146 | mg/kg bw | LD50 | oral | Rat (Male) | NTP_ICE_acute_oral |
| =161 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =186 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =0.75 | mg/kg bw/day | LEL | oral | Dog | ToxValDB_IRIS |
| =0.75 | mg/kg/day | LEL | oral | - | EPA_IRIS_iris_rfd_systems.csv |
| 1 | unitless | Relative reliability score | Dermal | Human | NTP_ICE_skin_sensitization |
| 3 | unitless | Relative reliability score | Dermal | Human | NTP_ICE_skin_sensitization |
| =0.0003 | mg/kg bw/day | RfD | oral | Human | ToxValDB_IRIS |
| =0.0003 | mg/kg/day | RfD | oral | - | EPA_IRIS_iris_rfd_systems.csv |
| =0.003 | mg/kg bw/day | RfD | oral | Human | ToxValDB_RSL |